GSK to sell Horlicks, may cut stake in India unit to fund $13b Novartis deal

GSK to sell Horlicks, may cut stake in India unit to fund $13b Novartis deal

Photo: Ramesh Pathania/Mint

GlaxoSmithKline Plc. (GSK) is exploring a partial or full sale of its 72.5% stake in its Indian unit GSK Consumer Healthcare Ltd, besides separately selling the company’s dietary supplement brand Horlicks as it looks to fund its $13 billion buyout of Novartis’s stake in a global consumer healthcare joint venture.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter